Revenue Growth Despite Challenges
Achieved a 9.8% year-over-year revenue growth, reaching USD 992 million, with support from the acquired consumer healthcare business and favorable Forex.
Emerging Markets Expansion
Emerging market revenue grew by 14% year-over-year and 18% sequentially, driven by new product launches and favorable Forex.
India Market Performance
India business reported a 13% year-over-year growth, driven by new product launches, improved pricing, and higher volumes.
Strategic Acquisitions and Partnerships
Acquired Stugeron brand in anti-vertigo segment and entered into partnerships for innovative therapies and biosimilars.
ESG Recognition
Retained MSCI ESG Rating of A and improved ESG Risk Rating from Morningstar Sustainalytics, demonstrating commitment to sustainability.